Results from proof-of-concept study are expected in September 2021. SAN DIEGO, July 08, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc....
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star” or the “Company”),...
OXFORD, United Kingdom, July 08, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the...
Proceeds of $17.5 Million Received Over 12-Month Expiration PeriodCINCINNATI, July 08, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt”...
Company’s Proprietary TAAP Prodrug Delivery and Overdose Technology Aims to Stem The Opioid Abuse EpidemicSAN DIEGO, July 08, 2021 (GLOBE...
THIS ANNOUNCEMENT IS FOR US ADS HOLDERS ONLY NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc...
CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a...
WARRINGTON, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR...
NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech...
Anticipates Net Revenue of $2.2 Million, Greater Than 40% Year-Over-Year Increase;Submits HDF Product to FDA for 510(k) Clearance SOUTH ORANGE,...
ADUHELM should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementiaCAMBRIDGE, Mass. and...
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE American: BTTR) (“Better Choice”), an animal health and...
Nhwa is conducting and funding this study to support NDA regulatory filing in China Trevena expects to receive approval and...
The company will analyze data based on patients enrolled to date in COVID-19 Phase II studies in U.S., Europe and...
TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger...
LONDON, July 08, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing therapies...
Brings 25 years of strategic leadership experience across healthcareCAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a...
Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™MISSISSAUGA, Ontario, July 08, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems...